News from the FDA/CDC

News from the FDA/CDC

Office visits have a chronic problem

Adult visits are more often for long term problems, but pediatric visits tend to be for acute conditions.


FDA approves biosimilar to bevacizumab

Bevacizumab-awwb is approved for the treatment of adults with certain colorectal, lung, brain, kidney, and cervical cancers.